HIGHLIGHTS
- What: None of the studies were found to have low risk of methodological bias or to have studied patient populations using regulated, oral cannabis-based medicines. The aim of this study was to investigate possible impairment to ‘next day` cognitive and psychomotor function, and simulated driving performance after a single oral dose of a typical cannabis oil by night, in adults with insomnia disorder. The study was approved by Bellberry Human Research Ethics Committee , and all participants provided written informed consent prior to study procedures. This study only examined a single dose.
- Who: Anastasia Suraev . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.